Amal Graafstra
Amal Graafstra, CEO of Dangerous Things and Vivokey is a Biohacker and Microchip implant developer, known for his work on implantable RFID/NFC human implantable microchip innovation and retail accessibility for the world market.[1] Prior to Dangerous Things, human implantable RFID technology wasn't well adopted with the human civilian population.[2]
Since 2008,[3] Amal has worked alongside multiple researchers and scientists to develop and produce NFC microchip implants and biohacking procedures.
Career[edit]
- 2013 - Founded Dangerous Things in Seattle
- 2013 - Built the first commercially available implantable NFC compliant transponder[4][5]
- 2017 - Founded Vivokey
- 2018 - Under Vivokey developed the first commercially available cryptographically-secure human implantable NFC transponders. The Vivokey Spark[6] as well as the Vivokey Flex One.
References[edit]
- ↑ CNBC.com, Andrew Zaleski, special to (2016-05-28). "This body hacker is turning people into cyborgs". CNBC. Retrieved 2020-09-25.
- ↑ Ismail, Kardo Kamaran, Podder A, Olsen N (2019). Adoption of Human Microchip Implants for Business Organizations (Thesis). Aalborg University.
- ↑ Ip, R.; Michael, Katina; Michael, M. (2008-06-24). "Amal Graafstra- The Do-It-Yourselfer RFID Implantee: The culture, values and ethics of hobbyist implantees: a case study". Faculty of Informatics - Papers (Archive).
- ↑ "Dangerous Things' xNT: a personal NFC chip in your hand". the Guardian. 2013-11-01. Retrieved 2020-09-25.
- ↑ "Brave New Coin". bravenewcoin.com. Retrieved 2020-09-25.
- ↑ Embodied computing : wearables, implantables, embeddables, ingestibles. Pedersen, Isabel. Cambridge, Massachusetts. 2020. ISBN 978-0-262-35779-1. OCLC 1129596819. Search this book on
Okay to publish page now?[edit]
This article "Amal Graafstra" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Amal Graafstra. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
